(anti-CD3-FITC/CD56+CD16-PE), anti-CD183/PercpCy5 (CXCR3), anti-CD196/PE (CCR6), anti-CD56-PE, antiCD16-Percp, anti-CD45-Amcyam (V500), anti-EPCAM-Percp, anti-CD64-FITC, anti-CD11b-PE, anti-CD161-APC and anti-CD33-Percp (BD Bioscience, San José, California, USA). For multiparametric analysis, a minimum of 4,000 events in lung tissues or 30,000 in peripheral blood in the lymphocyte collection gate (CD45 + versus SSClow) were collected in a FACS CantoTM II analyzer. Data were analyzed using BD FACSDiva Software v.8.01 (BD).
An electronic gate was set for CD45+/SSC low and a minimum of 10, 000 events in this gate were recorded for each sample. An additional electronic gate was made from the lymphocyte gate for T-cells (CD3 
Immunohistochemistry and image analysis
Tissue samples were fixed in 10% neutral formalin and embedded in paraffin; 4 μm-thick sections were taken from the paraffin blocks, mounted on pretreated slices, and stained for CD45, CD20, CD3, CD4 CD8 or CD68., using prediluted antibodies supplied by Master Diagnóstic ( Immunohistochemical staining was carried out using the of UltraVision Quanto (peroxidase) immunohistochemistry detection system (MAD-021881QK/MAD-001881QK Master Diagnóstica) following manufacturer's instructions. In short, paraffin sections were dewaxed and endogenous peroxidase activity blocked in a solution of hydrogen peroxide for 10 min. For antigen retrieval, sections were treated with sodium citrate buffer (pH 6.0). After incubation with the primary antibodies for 16 hours at 4ºC and washing 3 times with PBS for 5 minutes, tissue sections were again incubated for 10 min with the primary antibodies Amplificator (UltraVisionQuanto) and then washed, and incubated with the polymer Quanto (Ultra Vision Quanto) for 10 minutes. DAB was used as chromogen and sections were counterstained with hematoxylin.
No staining was obtained when non-immune serum or PBS was used instead of the primary antibody, confirming the specificity of the latter. All specimens were 
